These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

932 related items for PubMed ID: 14715867

  • 1. Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age.
    Laven JS, Mulders AG, Visser JA, Themmen AP, De Jong FH, Fauser BC.
    J Clin Endocrinol Metab; 2004 Jan; 89(1):318-23. PubMed ID: 14715867
    [Abstract] [Full Text] [Related]

  • 2. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS.
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [Abstract] [Full Text] [Related]

  • 3. Changes in anti-Müllerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility.
    Mulders AG, Laven JS, Eijkemans MJ, de Jong FH, Themmen AP, Fauser BC.
    Hum Reprod; 2004 Sep; 19(9):2036-42. PubMed ID: 15217995
    [Abstract] [Full Text] [Related]

  • 4. Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.
    Pigny P, Merlen E, Robert Y, Cortet-Rudelli C, Decanter C, Jonard S, Dewailly D.
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5957-62. PubMed ID: 14671196
    [Abstract] [Full Text] [Related]

  • 5. The relationship between serum anti-Müllerian hormone levels and the follicular arrest for women with polycystic ovary syndrome.
    Li J, Li R, Yu H, Zhao S, Yu Y, Qiao J.
    Syst Biol Reprod Med; 2015 Apr; 61(2):103-9. PubMed ID: 25329139
    [Abstract] [Full Text] [Related]

  • 6. Serum anti-mullerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women.
    Wachs DS, Coffler MS, Malcom PJ, Chang RJ.
    J Clin Endocrinol Metab; 2007 May; 92(5):1871-4. PubMed ID: 17299061
    [Abstract] [Full Text] [Related]

  • 7. Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women.
    Wongwananuruk T, Panichyawat N, Indhavivadhana S, Rattanachaiyanont M, Angsuwathana S, Techatraisak K, Pratumvinit B, Sa-Nga-Areekul N.
    Taiwan J Obstet Gynecol; 2018 Aug; 57(4):499-506. PubMed ID: 30122568
    [Abstract] [Full Text] [Related]

  • 8. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.
    Akush Ginekol (Sofiia); 2013 Aug; 52 Suppl 1():16-23. PubMed ID: 24294740
    [Abstract] [Full Text] [Related]

  • 9. The predictive value of circulating anti-Müllerian hormone in women with polycystic ovarian syndrome receiving clomiphene citrate: a prospective observational study.
    Mahran A, Abdelmeged A, El-Adawy AR, Eissa MK, Shaw RW, Amer SA.
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4170-5. PubMed ID: 23979947
    [Abstract] [Full Text] [Related]

  • 10. The role of anti-Müllerian hormone in the classification of anovulatory infertility.
    Lie Fong S, Schipper I, Valkenburg O, de Jong FH, Visser JA, Laven JS.
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():75-9. PubMed ID: 25666342
    [Abstract] [Full Text] [Related]

  • 11. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S, Laven JSE, Duhamel A, Dewailly D.
    Hum Reprod; 2017 Aug 01; 32(8):1723-1731. PubMed ID: 28854584
    [Abstract] [Full Text] [Related]

  • 12. Impact of laparoscopic ovarian drilling on anti-Müllerian hormone levels and ovarian stromal blood flow using three-dimensional power Doppler in women with anovulatory polycystic ovary syndrome.
    Elmashad AI.
    Fertil Steril; 2011 Jun 01; 95(7):2342-6, 2346.e1. PubMed ID: 21514928
    [Abstract] [Full Text] [Related]

  • 13. Serum anti-Müllerian hormone concentration in women with polycystic ovary syndrome and type 1 diabetes mellitus.
    Łebkowska A, Adamska A, Karczewska-Kupczewska M, Nikołajuk A, Otziomek E, Milewski R, Górska M, Wołczyński S, Kowalska I.
    Metabolism; 2016 May 01; 65(5):804-811. PubMed ID: 26961579
    [Abstract] [Full Text] [Related]

  • 14. Predictive markers for the FSH sensitivity of women with polycystic ovarian syndrome.
    Köninger A, Sauter L, Edimiris P, Kasimir-Bauer S, Kimmig R, Strowitzki T, Schmidt B.
    Hum Reprod; 2014 Mar 01; 29(3):518-24. PubMed ID: 24419495
    [Abstract] [Full Text] [Related]

  • 15. The role of anti-Müllerian hormone in the pathogenesis and pathophysiological characteristics of polycystic ovary syndrome.
    Qi X, Pang Y, Qiao J.
    Eur J Obstet Gynecol Reprod Biol; 2016 Apr 01; 199():82-7. PubMed ID: 26914398
    [Abstract] [Full Text] [Related]

  • 16. Absent biologically relevant associations between serum inhibin B concentrations and characteristics of polycystic ovary syndrome in normogonadotrophic anovulatory infertility.
    Laven JS, Imani B, Eijkemans MJ, de Jong FH, Fauser BC.
    Hum Reprod; 2001 Jul 01; 16(7):1359-64. PubMed ID: 11425813
    [Abstract] [Full Text] [Related]

  • 17. Changes in serum anti-mullerian hormone level during low-dose recombinant follicular-stimulating hormone therapy for anovulation in polycystic ovary syndrome.
    Catteau-Jonard S, Pigny P, Reyss AC, Decanter C, Poncelet E, Dewailly D.
    J Clin Endocrinol Metab; 2007 Nov 01; 92(11):4138-43. PubMed ID: 17698904
    [Abstract] [Full Text] [Related]

  • 18. The effect of different hormone therapies on anti-müllerian hormone serum levels in anovulatory women of reproductive age.
    Fábregues F, Castelo-Branco C, Carmona F, Guimerá M, Casamitjana R, Balasch J.
    Gynecol Endocrinol; 2011 Apr 01; 27(4):216-24. PubMed ID: 20500102
    [Abstract] [Full Text] [Related]

  • 19. Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome.
    Pigny P, Jonard S, Robert Y, Dewailly D.
    J Clin Endocrinol Metab; 2006 Mar 01; 91(3):941-5. PubMed ID: 16368745
    [Abstract] [Full Text] [Related]

  • 20. Anti-Müllerian hormone and antral follicle count for prediction of ovarian stimulation response in polycystic ovary syndrome.
    El-Mazny A, Abou-Salem N.
    Gynecol Endocrinol; 2013 Sep 01; 29(9):826-9. PubMed ID: 23855354
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.